Ahead of the upcoming COVAX AMC summit hosted by Germany on the 8th of April 2022, COVAX Civil Society and Community Representatives have issued a statement highlighting the urgent need for donors,

On 9 March 2022 Civil Society Representatives to the Therapeutics Pillar of the ACT-A sent a letter to Albert Bourla (Chairman and Chief Executive Officer at Pfizer) expressing concerns about

Civil Society and Community Representatives are pleased to share a white paper on community-based testing that explores the catalysts and bottlenecks at the heart of efforts to scale up this

On Monday February 22nd 2021, the Platform sent to the major actors within ACT-A a letter providing details about the changes civil society and communities are asking for in order

The Facilitation Council of the Access to COVID-19 Tools Accelerator (ACT-A) met on 9 December 2021. The meeting included a discussion on two key questions: • What are the most

Following the launch of the updated ACT-A strategy, civil society and community representatives to the Health Systems and Response Connector (HSRC) (previously theHealth Systems Connector (HSC)) wrote a letter to

Ahead of the ACT-A Facilitation Council meeting on Friday 15 October, the Platform has shared a letter with the Facilitation Council Co-chairs and lead agencies of ACT-A outlining key issues

Over a year and a half into the COVID-19 pandemic and the establishment of the Access to COVID-19 Tools Accelerator (ACT-A), questions about future pandemic preparedness responses are dominating global

Statement on Global COVID-19 Summit from ACT-A Civil Society Representatives Following the Global COVID-19 Summit: Ending the Pandemic and Building Back Better on 22 September, the civil society representatives to

Communities and Civil Society representatives in the ACT-A Diagnostics Pillar wrote to the Head of the WHO and others about the inequitable expansion of antigen rapid diagnostic tests (Ag RDT’s)